German AMNOG reform fails to hit the mark
04:20 EDT 21 Jun 2012 | SCRIP
Reform of Germany's early benefit assessments is currently under discussion, but the change floated looks unlikely to solve any of the main issues that are frustrating companies. During a recent debate in the German parliament, industry made little....
Original Article: German AMNOG reform fails to hit the mark
More From BioPortfolio on "German AMNOG reform fails to hit the mark"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
